Study: combination of varenicline and nicotine patch best way to quit smoking
Brooks HaysWASHINGTON, July 9 (UPI) -- The best way to quit smoking, researchers say, is a combination of a drug called varenicline and the use of nicotine patches. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 9, 2014 Category: Consumer Health News Source Type: news
Combining varenicline with nicotine patch boosts quit rates
Quitters more likely not to be smoking at six months with combination than with varenicline aloneRelated items from OnMedicaFewer smokers are using NHS help to quitSmoking cessationEU moves to make smoking less attractive to young smokersRoll-ups worse than factory-made cigarettesE-cigarettes may not help smokers quit (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 9, 2014 Category: UK Health Source Type: news
Combo Approach May Work Best for Smokers Looking to Quit
Study finds drug Chantix plus nicotine patch beats use of the patch alone (Source: WebMD Health)
Source: WebMD Health - July 8, 2014 Category: Consumer Health News Source Type: news
Patch Plus Pill Better to Help Smokers Quit (CME/CE)
(MedPage Today) -- Adding a nicotine patch to varenicline (Chantix) during quit-smoking attempts substantially improved short-term success in kicking the addiction, a trial showed. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 8, 2014 Category: Primary Care Source Type: news
Combo Approach May Work Best for Smokers Looking to Quit
Study finds drug Chantix plus nicotine patch beats use of the patch alone
Source: HealthDay
Related MedlinePlus Page: Quitting Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 8, 2014 Category: Consumer Health News Source Type: news
More Evidence Drug Combo Helps Smokers QuitMore Evidence Drug Combo Helps Smokers Quit
The combination of varenicline and bupropion proves successful in an 'adaptive' smoking cessation paradigm. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2014 Category: Consumer Health News Tags: Psychiatry News Source Type: news
E-cigs 'better than patches and gum' as quitting aid
Conclusion
This was a useful “real world” survey, which involved a large nationally representative sample of adults in England.
Researchers adjusted their results for a large number of potential confounders, including the degree of nicotine dependence and the time elapsed since participants’ attempt to quit begun.
However, as the authors point out, this was not an RCT, which is the best method of determining the effectiveness of treatments. This means that measured and unmeasured confounders could have affected the results.
Another important limitation is the study’s reliance on adults self-reporting whether th...
Source: NHS News Feed - May 21, 2014 Category: Consumer Health News Tags: Heart/lungs Lifestyle/exercise Source Type: news
No age discrimination pledge in drugs appraisals
NICE launches consultation on how it assesses drugs and treatments Related items from OnMedicaStart varenicline sooner to boost successSleeping pills linked to fourfold death riskNew guidance for elderly with high BP‘Scorecards’ will eradicate NHS drug inequalitySugar not saturated fat is the major issue for CVD (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 28, 2014 Category: UK Health Source Type: news
More Evidence Varenicline Helps Mentally Ill Quit SmokingMore Evidence Varenicline Helps Mentally Ill Quit Smoking
Varenicline helps smokers with serious mental illness abstain from smoking, new research shows. But at least 1 expert is still not entirely convinced of its safety in this patient population. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - February 10, 2014 Category: Psychiatry Tags: Psychiatry News Source Type: news
Medication may help patients with severe mental illness stay smoke-free
Smokers with schizophrenia or bipolar disorders are three times more likely to abstain from smoking over the course of a year if they take varenicline.
Although varenicline is an FDA-approved smoking cessation medication, it had not been proven effective for smokers with severe mental illness. The... (Source: NIDA News)
Source: NIDA News - February 4, 2014 Category: Addiction Tags: Mental Health, Prevention Research Source Type: news
Drug Combo Boosts Early Quit Rates in SmokersDrug Combo Boosts Early Quit Rates in Smokers
Combining varenicline with bupropion may boost early quit rates compared with varenicline alone; heavier smokers most likely to benefit. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - January 9, 2014 Category: Psychiatry Tags: Psychiatry News Source Type: news
Combined Therapy Benefits Cigarette Smokers Trying to Quit Compared to Monotherapy
ROCHESTER, Minn. — Jan. 7, 2014 — Among cigarette smokers, combining the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in higher smoking abstinence rates for one outcome but not the other at three and six months; rates were similar at one year, according to a Mayo Clinic study published this month [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - January 7, 2014 Category: Research Source Type: news
'No serious heart risks' linked to smoking cessation therapies
The American Heart Association claims that three different types of smoking cessation therapies do not pose serious heart risks, quashing concerns that certain products may increase the risks of heart attack, stroke or heart-related death.Researchers looked at the results of 63 clinical trials involving 30, 508 people who were quitting smoking using either nicotine replacement gums and patches, the nicotine addiction treatment varenicline (Chantix), or taking the antidepressant bupropion (Wellbutrin), which can reduce cravings and other unwanted withdrawal effects. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 13, 2013 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news
Quit-smoking drug to make problem drinking 'social'
A drug commonly used to help people quit smoking may also help problem drinkers overcome their addiction.Professor Selena Bartlett from QUT's Institute of Health and Biomedical Innovation (IHBI) and an ambassador for Women in Technology (WiT) said trials would soon begin to test whether varenicline, commonly known as Champix, can effectively treat problem drinkers."It's well known that many people with serious alcohol dependency also smoke so we've been trying to better understand the mechanisms behind that," Professor Bartlett said. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 28, 2013 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news
Chantix OK with Treated Depression
A new study says that for those who have their depression under control with treatment, it is safe to take the smoking cessation drug Chantix (varenicline).
The study follows a 2007 report from the U.S. Food and Drug Administration (FDA) revealing that there had been complaints of suicidal thoughts and erratic behavior in some who used the drug. The report said that it was not clear whether the drug was to blame for these symptoms or if they were caused by nicotine withdrawal....Read Full Post (Source: About.com Depression)
Source: About.com Depression - September 23, 2013 Category: Psychiatry Source Type: news
